Q32 Bio Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Q32 Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.38M, a 359% increase year-over-year.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.55M, a 139% increase year-over-year.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.32M, a 43.9% decline from 2022.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.1M, a 24.3% decline from 2021.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.2M, a 30.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.32M -$5.73M -43.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $13.1M -$4.19M -24.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $17.2M +$4M +30.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $13.2M +$5.61M +73.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $7.64M +$5.01M +191% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $2.62M +$2.37M +925% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $256K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.